Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Zhishen Ruan, Dan Li, Yuanlong Hu, Zhanjun Qiu & Xianhai Chen. (2022) The Association of Renin-Angiotensin System Blockades and Mortality in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Acute Respiratory Failure: A Retrospective Cohort Study. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2001-2011.
Read now
Read now
Ioannis E. Vasileiadis, Christos A. Goudis, Pinelopi T. Giannakopoulou & Tong Liu. (2018) Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Promising Medication for Chronic Obstructive Pulmonary Disease?. COPD: Journal of Chronic Obstructive Pulmonary Disease 15:2, pages 148-156.
Read now
Read now
Chih-Cheng Lai, Ya-Hui Wang, Cheng-Yi Wang, Hao-Chien Wang, Chong-Jen Yu & Likwang Chen. (2018) Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 867-874.
Read now
Read now
Articles from other publishers (21)
Frida Vilstrup, Christian Kjer Heerfordt, Peter Kamstrup, Caroline Hedsund, Tor Biering-Sørensen, Rikke Sørensen, Shailesh Kolekar, Ole Hilberg, Lars Pedersen, Thomas Kromann Lund, Tobias Wirenfeldt Klausen, Kristoffer Grundtvig Skaarup, Josefin Eklöf, Pradeesh Sivapalan & Jens-Ulrik Stæhr Jensen. (2023) Renin–angiotensin–system inhibitors and the risk of exacerbations in chronic obstructive pulmonary disease: a nationwide registry study. BMJ Open Respiratory Research 10:1, pages e001428.
Crossref
Crossref
Hongzhen Lv, Jingyi Huang, Miao Miao, Cheng Huang, Wenlu Hang & Yong Xu. (2023) Could patients with chronic obstructive pulmonary disease benefit from renin angiotensin system inhibitors? A meta-analysis. BMJ Open Respiratory Research 10:1, pages e001569.
Crossref
Crossref
Jana Heidemann, Marcel Konrad, Christoph Roderburg, Sven H. Loosen & Karel Kostev. (2022) Association between Antihypertensive Therapy and Risk of Acute Lower Respiratory Infections (ALRI): A Retrospective Cohort Study. Healthcare 10:11, pages 2318.
Crossref
Crossref
Fumiki Yoshihara, Hiroshi Ohtsu, Michikazu Nakai, Shinya Tsuzuki, Kayoko Hayakawa, Mari Terada, Nobuaki Matsunaga, Satoshi Yasuda, Hisao Ogawa & Norio Ohmagari. (2022) Renin-angiotensin system blocker and the COVID-19 aggravation in patients with hypertension, diabetes, renal failure, Cerebro-cardiovascular disease, or pulmonary disease: Report by the COVID-19 Registry Japan. Journal of Cardiology 80:4, pages 292-297.
Crossref
Crossref
Jae-Hyun Yun, Seung Yeon Rhee, Sungyoun Chun, Hyoung Seop Kim & Byung-Mo Oh. (2022) Association Between Antihypertensive Use and Hospitalized Pneumonia in Patients With Stroke: A Korean Nationwide Population-Based Cohort Study. Journal of Korean Medical Science 37:15.
Crossref
Crossref
Michelle N. Eakin & Enid Neptune. (2021) Smoking and COVID-19: The Real Deal. Annals of the American Thoracic Society 18:10, pages 1610-1613.
Crossref
Crossref
Elisabeth Fließer, Anna Birnhuber, Leigh M Marsh, Elisabeth Gschwandtner, Walter Klepetko, Horst Olschewski & Grazyna Kwapiszewska. (2021)
Dysbalance of
ACE2
levels – a possible cause for severe
COVID
‐19 outcome in
COPD
. The Journal of Pathology: Clinical Research 7:5, pages 446-458.
Crossref
Crossref
Juan M. Saavedra. (2021) Angiotensin Receptor Blockers Are Not Just for Hypertension Anymore. Physiology 36:3, pages 160-173.
Crossref
Crossref
Hyun Woo Lee, Chang-Hwan Yoon, Eun Jin Jang & Chang-Hoon Lee. (2021) Renin-angiotensin system blocker and outcomes of COVID-19: a systematic review and meta-analysis. Thorax 76:5, pages 479-486.
Crossref
Crossref
Shih-Yi Lin, Shu-Woei Ju, Cheng-Li Lin, Cheng-Chieh Lin, Wu-Huei Hsu, Chia-Hui Chou, Chih-Yu Chi, Chung-Y Hsu & Chia-Hung Kao. (2020) Risk of Viral Infection in Patients Using Either Angiotensin-converting Enzyme Inhibitors or Angiotensin Receptor Blockers: A Nationwide Population-based Propensity Score Matching Study. Clinical Infectious Diseases 71:10, pages 2695-2701.
Crossref
Crossref
Dan Mei, W.S. Daniel Tan, Wupeng Liao, C.K. Matthew Heng & W.S. Fred Wong. (2020) Activation of angiotensin II type-2 receptor protects against cigarette smoke-induced COPD. Pharmacological Research 161, pages 105223.
Crossref
Crossref
Abdel G. Elkahloun & Juan M. Saavedra. (2020) Candesartan could ameliorate the COVID-19 cytokine storm. Biomedicine & Pharmacotherapy 131, pages 110653.
Crossref
Crossref
Jaroslav Hrenak & Fedor Simko. (2020) Renin–Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome. International Journal of Molecular Sciences 21:21, pages 8038.
Crossref
Crossref
Juan M. Saavedra. (2020) COVID-19, Angiotensin Receptor Blockers, and the Brain. Cellular and Molecular Neurobiology 40:5, pages 667-674.
Crossref
Crossref
Josuel Ora, Francesco Cavalli & Mario Cazzola. 2020. Cardiovascular Complications of Respiratory Disorders. Cardiovascular Complications of Respiratory Disorders
66
81
.
Chhinder P. Sodhi, Jenny Nguyen, Yukihiro Yamaguchi, Adam D. Werts, Peng Lu, Mitchell R. Ladd, William B. Fulton, Mark L. Kovler, Sanxia Wang, Thomas PrindleJr.Jr., Yong Zhang, Eric D. Lazartigues, Michael J. Holtzman, John F. Alcorn, David J. Hackam & Hongpeng Jia. (2019)
A Dynamic Variation of Pulmonary ACE2 Is Required to Modulate Neutrophilic Inflammation in Response to
Pseudomonas aeruginosa
Lung Infection in Mice
. The Journal of Immunology 203:11, pages 3000-3012.
Crossref
Crossref
YASIN BAYIR, HARUN UN, ELIF CADIRCI, EROL AKPINAR, BUSRA DIYARBAKIR, ILKNUR CALIK & ZEKAI HALICI. (2019) Effects of Aliskiren, an RAAS inhibitor, on a carrageenan-induced pleurisy model of rats. Anais da Academia Brasileira de Ciências 91:1.
Crossref
Crossref
Chih-Cheng LaiYa-Hui WangCheng-Yi WangHao-Chien WangChong-Jen YuLikwang Chen. (2019) Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers. Critical Care Medicine 47:1, pages e14-e20.
Crossref
Crossref
Francesca Polverino, Bartolome R. Celli & Caroline A. Owen. (2018) Reply to Voelkel: Cigarette Smoke Is an Endothelial Cell Toxin. American Journal of Respiratory and Critical Care Medicine 197:2, pages 274-275.
Crossref
Crossref
Francesca Polverino, Bartolome R. Celli & Caroline A. Owen. (2018) COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series). Pulmonary Circulation 8:1, pages 1-18.
Crossref
Crossref
Mario Cazzola, Luigino Calzetta, Barbara Rinaldi, Clive Page, Giuseppe Rosano, Paola Rogliani & Maria Gabriella Matera. (2017) Management of Chronic Obstructive Pulmonary Disease in Patients with Cardiovascular Diseases. Drugs 77:7, pages 721-732.
Crossref
Crossref